Innovent/GenFleet Score China’s First KRAS G12C Inhibitor Approval

Homegrown Competition Looming

 
• By Dexter Jie Yan
first to hit the line
Innovent/GenFlee hit finish line for China's first approved KRAS G12C inhibitor • Source: Shutterstock

More from China

More from Focus On Asia